Intermittent Fasting as a Potential Therapeutic Instrument for Major Depression Disorder: A Systematic Review of Clinical and Preclinical Studies
Murta L, Seixas D, Harada L, Damiano RF, Zanetti M
International journal of molecular sciences · 24 citas
Cómo se estudió
- Diseño
- Revisión sistemática (indexado por PubMed)
- Estudiado en
- Personas, más trabajo en animales o laboratorio
- Resultado principal
- Marcadores de salud y funcionamiento
Quién lo pagó
- Financiación
- Financiación independiente
Según la declaración de financiación del texto completo.
Publicación
- Publicado
- 2023-10-25 · Int J Mol Sci · vol. 24 · número 21 · pág. 15551
- Editorial
- Multidisciplinary Digital Publishing Institute
- Citado
- 30 citas · más que el 82% de estudios similares · 1.5× el promedio de su campo
- Referencias
- 77 trabajos
- Acceso
- Acceso abierto (revista) · CC-BY
- Áreas de investigación
- Dietary Effects on Health · Treatment of Major Depression · Tryptophan and brain disorders
- Palabras clave
- intermittent fasting, major depressive disorder, mood disorders, circadian regulation, neurotrophic factors, animal models of depression
- MeSH
- brain, humans, depression, mood disorders, intermittent fasting, major depressive disorder
5 autores
- Laís de Deus Murta Nery🇧🇷 · autor de correspondenciaHospital Sírio-Libanês
- Daniela Seixas🇧🇷Universidade de São Paulo
- Luana Harada🇧🇷Hospital Sírio-Libanês
- Rodolfo Furlan Damiano🇧🇷Universidade de São Paulo
- Marcus V. Zanetti🇧🇷Hospital Sírio-Libanês
Resumen
El texto original del estudio, en el idioma en que se publicó.
Recent studies have reported positive effects of Intermittent Fasting (IF) on metabolic parameters, cognition, and mood. However, regarding depressive symptoms, the effect of IF is not clear. The purpose of this review was to assess the available evidence on IF interventions for depression in both clinical and preclinical studies. Of the 23 included studies, 15 were performed on humans and 8 on animal models. The studies on rodents suggested that IF acts as a circadian regulator, improving neurotransmitter availability and increasing the levels of neurotrophic factors in the brain. However, the investigations on humans mainly evaluated healthy volunteers and showed a great heterogeneity regarding both the IF regimen studied and the observed effects on mood. Most available clinical trials have specific limitations, such as small sample sizes and uncontrolled designs. A comprehensive systematic review was conducted on five databases, PubMed, Cochrane, the Central Register of Controlled Trials, Web of Science databases, BVS and Scopus, identifying 23 relevant studies up to 6 October 2022. IF has potentially relevant physiological effects for the treatment of mood disorders, but better designed studies and controlled evaluations are needed to evaluate its efficiency in the treatment of major depression.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY).
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.